AMINOCAPROIC ACID - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for aminocaproic acid and what is the scope of patent protection?
Aminocaproic acid
is the generic ingredient in four branded drugs marketed by Epic Pharma Llc, Abraxis Pharm, Baxter Hlthcare, Hospira, Luitpold, Hikma, Amneal, Annora Pharma, Aurobindo Pharma, Belcher, Carnegie, Florida, Sunny, Taro, Tulex Pharms Inc, Vistapharm Llc, Ani Pharms, Edenbridge Pharms, MSN, and Optimus, and is included in twenty-seven NDAs. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for aminocaproic acid. Twenty suppliers are listed for this compound.
Summary for AMINOCAPROIC ACID
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 20 |
NDAs: | 27 |
Drug Master File Entries: | 6 |
Finished Product Suppliers / Packagers: | 20 |
Raw Ingredient (Bulk) Api Vendors: | 183 |
Clinical Trials: | 37 |
Patent Applications: | 9,354 |
Drug Prices: | Drug price trends for AMINOCAPROIC ACID |
What excipients (inactive ingredients) are in AMINOCAPROIC ACID? | AMINOCAPROIC ACID excipients list |
DailyMed Link: | AMINOCAPROIC ACID at DailyMed |
Recent Clinical Trials for AMINOCAPROIC ACID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Minia University | Phase 3 |
NYU Langone Health | N/A |
Assiut University | Phase 4 |
Pharmacology for AMINOCAPROIC ACID
Drug Class | Antifibrinolytic Agent |
Physiological Effect | Decreased Fibrinolysis |
Medical Subject Heading (MeSH) Categories for AMINOCAPROIC ACID
Anatomical Therapeutic Chemical (ATC) Classes for AMINOCAPROIC ACID
US Patents and Regulatory Information for AMINOCAPROIC ACID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Florida | AMINOCAPROIC ACID | aminocaproic acid | SOLUTION;ORAL | 215510-001 | Mar 23, 2022 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Taro | AMINOCAPROIC ACID | aminocaproic acid | SOLUTION;ORAL | 214458-001 | Mar 24, 2023 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ani Pharms | AMINOCAPROIC ACID | aminocaproic acid | TABLET;ORAL | 211629-001 | Dec 14, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.